Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. - Wikidata - awgldk - TriplyDB

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

http://www.wikidata.org/entity/Q34025073

about

Bacteria and tumours: causative agents or opportunistic inhabitants?Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes Accessing the inaccessible: molecular tools for bifidobacteria High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting Gut Bifidobacteria Populations in Human Health and Aging A Phytase-Based Reporter System for Identification of Functional Secretion Signals in Bifidobacteria Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.Intratumoural production of TNFα by bacteria mediates cancer therapy.Genomic insights into bifidobacteria Transposon mutagenesis in Bifidobacterium breve: construction and characterization of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003 Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor Programmable probiotics for detection of cancer in urine.Local bacteria affect the efficacy of chemotherapeutic drugs.Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.Genomics of the Genus Bifidobacterium Reveals Species-Specific Adaptation to the Glycan-Rich Gut Environment Bioluminescent bacterial imaging in vivo.Bifidobacterium population analysis in the infant gut by direct mapping of genomic hybridization patterns: potential for monitoring temporal development and effects of dietary regimens Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions.Bacteria as vectors for gene therapy of cancer.Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives.Bacterial vectors for imaging and cancer gene therapy: a review.Mobilome and genetic modification of bifidobacteria.Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy.Controlled gene expression in bifidobacteria by use of a bile-responsive element.Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice.Production of biologically active scFv and VHH antibody fragments in Bifidobacterium longum.Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo.Physiological Translocation of Lactic Acid Bacteria during Pregnancy Contributes to the Composition of the Milk Microbiota in Mice.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease

P2860

Q24617952-BC72D273-D0EF-49C6-B3E1-AD221C802AE6 Q26786083-2572CFF8-6CD8-4298-A2AC-8F4800C7DFE0 Q27015839-1409D84C-AB28-4F99-8CB3-613D4C9FAF28 Q27309184-8C94D6BC-65D3-42A4-8EFA-1BF5FAB01D82 Q28071697-11BD4556-9E57-426F-A532-9BC3C2CBFA9B Q28548451-C81DB015-7167-4CF0-89C5-71650103E246 Q33724207-5F933020-5BA7-48F6-A7F4-F169C6926494 Q33853333-11F2D52C-4912-42EA-B67F-A08549E75F2F Q34119622-14AC8FA4-27AF-4B0E-9A85-7BB6CD2D6B34 Q34758875-6144E6FB-F14A-473A-AC04-151C8666D6C0 Q35090999-4BB18958-989D-430E-BD37-918B7193BF3D Q35879638-9373BCCC-894D-466E-ADF4-93B0A1F630E2 Q36102269-1770E74E-E916-4669-8E28-5E4FA99D269C Q36523130-A46705A8-308C-478A-B30F-AB91FEBDA6C1 Q36575131-D980E976-C81C-4EB7-B7FC-BB2CEDDA1C91 Q36626348-7375F979-A050-40C2-A06E-864E071F77A6 Q37283910-DBFDB5D9-6C04-4471-AC04-C550D488D7DC Q37355548-7BB3F810-9EB8-4360-BD3B-CC7502D20893 Q37713116-D20D8A46-519C-4C6B-9439-36A9F6208B86 Q37862087-3739AFF7-53D8-4033-A627-ED15566F3C39 Q37961560-E7237053-BD4C-406F-A3FB-2F99DB1E3A67 Q38045229-4EB3EFE4-C3DA-42D6-87FC-64A77FADA61C Q38070061-FD649E57-E896-450F-9BB1-8A155FE0D806 Q38812773-CA4EF42C-B75C-43CE-B398-164781325351 Q40316018-8800D3C1-E0CC-4B19-8FBC-FE26AAD33DFD Q41235877-F7BDF83F-0921-48B2-9385-C9B2AB586FA7 Q41726225-5C0E6F4F-BFC5-4544-948F-6817E6500F12 Q45870726-5BAA1A1F-E1EA-4716-B2E2-65F5C152A5F5 Q48320085-65AEC208-011A-4D2C-88F8-9A0C66E27635 Q50532218-E922BA50-A5B7-4FB6-A13B-18DBA40AFD94 Q58126740-54D64BF9-F07E-41BE-B2A9-188CC540C098

P2860

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

http://www.wikidata.org/entity/Q34025073

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@ast

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@en

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@nl

type

label

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@ast

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@en

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@nl

prefLabel

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@ast

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@en

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@nl

P1433

Q34025073-1EED7398-D9CB-45A3-887C-5C8982E6608E

P1476

Q34025073-410485D1-48E1-4FEC-B12C-C4E72693BA13

P2093

Q34025073-4FD77637-49E2-40DF-94FD-003DE7F0C0EA

Q34025073-503DCCD1-2C55-4284-B607-04BBE5F0D679

Q34025073-705E9E59-2202-407D-9619-9F8B3E49580B

Q34025073-AEF417CC-2F27-48BA-9A92-C8B5ADDF8380

Q34025073-D6BFD020-2CF6-4126-9DCB-F2BA53FA2914

Q34025073-F4D39D1B-70F6-4CD8-90B0-58CA8F49A46B

P2860

Q34025073-10FE70BA-483E-45E0-BDAB-4EB55B09A922

Q34025073-184F55CE-41CC-4185-AA03-C453A9E42046

Q34025073-1EB41C93-2CF5-425F-8617-20E4809AD3D5

Q34025073-245442E9-1735-43EF-AEA8-A17128BF8C77

Q34025073-24CAB8F6-47C8-4F0A-A4DF-5D30FE3B138D

Q34025073-301CD574-720F-41FF-84EA-00525A543616

Q34025073-31348CCC-B42C-4F0C-BD1B-880385ED31F2

Q34025073-36B08245-D49C-4821-BA48-7CCC75D2A3C7

Q34025073-3B3E6954-BA43-45A7-9D5F-4793DAB11162

Q34025073-401E2146-9506-4E7D-B282-01A694D805F8

P304

Q34025073-E699C6D5-E676-447C-98EB-35966E83D577

P31

Q34025073-961AEB8C-890A-4F52-8DD1-DA0B72CF31CB

P356

Q34025073-CBC972C9-F1D4-40B3-8D06-0B4476A40F2F

P433

Q34025073-1AFF9C5A-F652-43A4-9435-5A7E2034D119

P478

Q34025073-E1A4ED12-1507-41BE-AE27-E4FAD99DEA40

P50

Q34025073-F4E4449C-ABFB-4BDF-B3C7-2A71A837214B

P577

Q34025073-005F6FB6-42E0-4975-A4C7-B20C29175353

P5875

Q34025073-76C9961A-486D-4269-8665-447CD5FCD11D

P698

Q34025073-227B8444-A3EB-4F2F-83E5-372B732B166B

P932

Q34025073-2E9FE094-7C72-4A72-A87E-E7E952317CA0

P356

P1433

Molecular Therapy

P1476

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

@en

P2093

David Morrissey

http://www.w3.org/2001/XMLSchema#string

Gerald C O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Mark Tangney

http://www.w3.org/2001/XMLSchema#string

Michelle Cronin

http://www.w3.org/2001/XMLSchema#string

Shereen M El Mashad

http://www.w3.org/2001/XMLSchema#string

Simon Rajendran

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium.

Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum.

Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

Bacterial translocation from the gastrointestinal tract.

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.

Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice.

Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model

Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract of mice by bacterial antagonism

Probiotics and safety.

P304

1397-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.59

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Douwe van Sinderen

P577

2010-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43134315

http://www.w3.org/2001/XMLSchema#string

P698

20389288

http://www.w3.org/2001/XMLSchema#string

P932

2911250

http://www.w3.org/2001/XMLSchema#string